Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19.
Fujimura T, Tanita K, Sato Y, Lyu C, Kambayashi Y, Fujisawa Y, Uchi H, Yamamoto Y, Otsuka A, Yoshino K, Matsushita S, Funakoshi T, Fukushima S, Hata H, Hashimoto A, Aiba S.
Fujimura T, et al. Among authors: aiba s.
Br J Dermatol. 2020 May;182(5):1297-1300. doi: 10.1111/bjd.18721. Epub 2019 Dec 17.
Br J Dermatol. 2020.
PMID: 31746456
No abstract available.